Research Project

Project Title:	A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis (MISSION)
Project Type:	Clinical Trial, Enrolment ongoing
Disease group(s):	Immune glomerulopathies
Project Summary:	The MISSION study (NCT03393013) is a Phase 1b/2, open-label study to evaluate safety, tolerability, and preliminary efficacy of zetomipzomib in patients with SLE with ± LN.
Lead principal investigator(s):	Smaragdi Marinaki, Athens
Co-investigator(s):	Ioannis Boletis, Athens Chrysanthi Skalioti, Athens
Project Period:	01/2024 - 01/2025
ClinicalTrials.gov:	NCT03393013